« Back to Record
Piccart-Gebhart, M., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R. H., Jackisch, C., Cameron, D. A., Dowsett, M., Barrios, C. H., Steger, G., Huang, C.-S., Andersson, M., Inbar, M., Lichinitser, M., Lang, I., Nitz, U., Iwata, H., Thomssen, C., Lohrisch, C., Suter, T., Rüschoff, J., Sütö, T., Greatorex, V., Ward, D., Straehle, C., McFadden, E., Dolci, S., Gelber, R. D., & HERA study team, (2005). Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. The New England journal of medicine, 353(16), 1659-1672. doi:10.1056/NEJMoa052306
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55795



